387 related articles for article (PubMed ID: 19049844)
41. Haemostatic effects of phytoestrogen genistein in postmenopausal women.
Trifiletti A; Gaudio A; Lasco A; Atteritano M; Scamardi R; Pizzoleo MA; Morabito N; Frisina N
Thromb Res; 2008; 123(2):231-5. PubMed ID: 18410952
[TBL] [Abstract][Full Text] [Related]
42. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
Zhou H; Chen R; Liu X
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
[TBL] [Abstract][Full Text] [Related]
43. Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia.
Lucena FC; Lage EM; Teixeira PG; Barbosa AS; Diniz R; Lwaleed B; Talvani A; Alpoim PN; Perucci LO; Dusse LMS
Hypertens Pregnancy; 2019 Feb; 38(1):58-63. PubMed ID: 30760065
[TBL] [Abstract][Full Text] [Related]
44. Maternal plasma D-dimer levels in normal and complicated pregnancies.
Nolan TE; Smith RP; Devoe LD
Obstet Gynecol; 1993 Feb; 81(2):235-8. PubMed ID: 8423957
[TBL] [Abstract][Full Text] [Related]
45. Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy.
Yin KH; Koh SC; Malcus P; SvenMontan S; Biswas A; Arulkumaran S; Ratnam SS
J Obstet Gynaecol Res; 1998 Jun; 24(3):231-8. PubMed ID: 9714995
[TBL] [Abstract][Full Text] [Related]
46. Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis.
Giddings JC; Morris RJ; Ralis HM; Jennings GM; Davies DA; Woodcock JP
Clin Lab Haematol; 2004 Aug; 26(4):269-73. PubMed ID: 15279664
[TBL] [Abstract][Full Text] [Related]
47. Hemostatic abnormalities in patients with severe preeclampsia.
Heilmann L; Rath W; Pollow K
Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
[TBL] [Abstract][Full Text] [Related]
48. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
49. Negative correlation between D-dimer and plasminogen activator inhibitor-1 levels is absent in obese women.
Ceo PT; Petruceli E; Bosco AA; Andrade-Fernandes CM; Russi CV; Carvalho Md; Sandrim VC
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):402-5. PubMed ID: 22527291
[TBL] [Abstract][Full Text] [Related]
50. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
51. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
52. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
Parry DJ; Grant PJ; Scott DJ
Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
[TBL] [Abstract][Full Text] [Related]
53. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
54. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the pro-thrombotic state in CAPD patients.
Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
[TBL] [Abstract][Full Text] [Related]
56. Fibrin D-dimer, haemostatic factors and peripheral arterial disease.
Lee AJ; Fowkes FG; Lowe GD; Rumley A
Thromb Haemost; 1995 Sep; 74(3):828-32. PubMed ID: 8571305
[TBL] [Abstract][Full Text] [Related]
57. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
Trofatter KF; Howell ML; Greenberg CS; Hage ML
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
[TBL] [Abstract][Full Text] [Related]
58. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
[TBL] [Abstract][Full Text] [Related]
59. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
Jin L; Jin H; Zhang G; Xu G
Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
[TBL] [Abstract][Full Text] [Related]
60. [Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].
Ma S; Bai C; Bian X
Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):712-4. PubMed ID: 11479955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
